Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2018MedicineOpen Access

Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

JZJian ZhangMZManka ZhangHMHuimin Ma

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2018) studied this question.

synapsesocial.com/papers/6a87c4e56841b83273ad2a96https://doi.org/10.1097/md.0000000000011130
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hepatocellular Carcinoma: Epidemiology, Surveillance, and Diagnosis2010 · 402 citations
  2. 2Glypicans2008 · 543 citations
  3. 3Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas2011 · 20 citations
  4. 4Glypican-32009 · 107 citations
  5. 5Glypican-3 Expression Distinguishes Small Hepatocellular Carcinomas From Cirrhosis, Dysplastic Nodules, and Focal Nodular Hyperplasia-like Nodules2006 · 272 citations